Serotonergic drugs - A possible role in the treatment of psoriasis?

Drug News and Perspectives

Volumn 20, Issue 8, 2007, Pages 521-525

  Thorslund, Kristofer ^a   Nordlind, Klas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); BUSPIRONE; FLUOXETINE; KETANSERIN; ONDANSETRON; PAROXETINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TANDOSPIRONE; TRYPTOPHAN;

ACNE; ANGIONEUROTIC EDEMA; ATOPIC DERMATITIS; CONTACT DERMATITIS; DEGRADATION; DRUG TARGETING; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LEUKOCYTOCLASTIC VASCULITIS; NONHUMAN; PRURITUS; PSORIASIS; REVIEW; SEROTONIN UPTAKE; SKIN INFLAMMATION; STEVENS JOHNSON SYNDROME; STRESS; SYNTHESIS; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS; URTICARIA;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; PSORIASIS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGENTS;

EID: 38749126841     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2007.20.8.1157614     Document Type: Review

References (42)

1. Szepietowski, J.C., Reich, A. and Wisnicka B. Pruritus and Psoriasis. Br J Dermatol 2004, 151(6): 1272-88.
2. Gudjonsson, J.E., Johnston, A., Dyson, M., Valdimarsson, H. and Elder, J.T. Mouse models of psoriasis. J Invest Dermatol 2007, 127(6): 1292-308.
3. Bos, J.D. Psoriasis, innate immunity, and gene pools. J Am Acad Dermatol 2007, 56(3): 468-71.
4. Naukkarinen, A., Harvima, I.T., Aalto, M.L. and Horsmanheimo, M. Mast cell tryptase and chymase are regulators of neurogenic inflammation in psoriatic skin. Int J Dermatol 1994, 33(5): 361-6.
5. Griffiths, C.E.M. and Richards, H.L. Psychological influences in psoriasis. Clin Exp Dermatol 2001, 26(4): 338-42.
6. Collier, H.O.J. The occurrence of 5-hydroxytryptamine (5-HT) in nature. Pergamon: New York, 1958.
7. Azmitia, E.C. Serotonin and brain: Evolution, neuroplasticity, and homeostasis. Int Rev Neurobiol 2007, 77: 31-56.
8. Boeckaert, J., Claeysen, S., Bécamel, C., Dumuis, A. and Marin P. Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. Cell Tissue Res 2006, 326(2): 553-72.
9. Azmitia, E.C. and McEwen, B.S. Corticosterone regulation of tryptophan hydroxylase in midbrain of the rat. Science 1969, 166(910): 1274-6.
10. Azmitia, E.C., Liao, B. and Chen, Y. Increase of tryptophan hydroxylase enzyme protein by dexamethasone in adrenalectomized rat midbrain. J Neurosci 1993, 13(12): 5041-55.
11. Azmitia, E.C. Modern views on an ancient chemical: Serotonin effects on cell proliferation, maturation and apoptosis. Brain Res Bull 2002, 56(5): 413-24.
12. Azmitia, E.C. Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropharmacol 1999, 21 (Suppl. 2): 33S-45S.
13. Mockus, S.M. and Vrana, K.E. Advances in the molecular characterization of tryptophan hydroxylase. J Mol Neurosci 1998, 10(3): 163-79.
14. Slominski, A., Pisarchik, A., Johansson, O., Jing, C., Semak, I., Slugocki, G. and Wortsman J. Tryptophan hydroxylase expression in human skin cells. Biochim Biophys Acta 2003, 1639(2): 80-6.
15. Slominski, A., Wortsman, J. and Tobin, D.J. The cutaneous serotoninergic/melatoninergic system: Securing a place under the sun. FASEB J 2005, 19(2): 176-94.
16. Mitani, H., Shirayama, Y., Yamada, T. and Kawahara R. Plasma levels of homovanillic acid, 5-hydroxyindoleacetic acid and cortisol, and serotonin turnover in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30(3): 531-4.
17. Rang, H.P., Dale, M.M, Ritter, J.M. and Moore, P.K. Other peripheral mediators: 5-hydroxytryptamine and purines. In: Pharmacology, Fifth ed. Churchill Livingstone: London 2003, 184-97.
18. Lesch, K.P. and Gutknecht, L. Pharmacogenetics of the serotonin transporter. Progr Neuropsychopharmacol Biol Psychiatry 2005, 29(6): 1062-73.
19. Wendland, J.R., Martin, B.J., Kruse, M.R., Lesch, K.P. and Murphy, D.L. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiat 2006, 11(3): 224-6.
20. Slominski, A., Pisarchik, A., Zbytek, B., Tobin, D.J., Kauser, S. and Wortsman, J. Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol 2003, 196(1): 144-53.
21. Lundeberg, L., El-Nour, H., Mohabbati, S., Morales, M., Azmitia, E.C. and Nordlind, K. Expression of serotonin receptors in allergic contact eczematous human skin. Arch Dermatol Res 2002, 294(9): 393-8.
22. Nordlind, K., Thorslund, K., Lonne-Rahm, S., Mohabbati, S., Berki, T., Morales, M. and Azmitia, E.C. Expression of serotonergic receptors in psoriatic skin. Arch Dermatol Res 2006, 298(3): 99-106.
23. Weisshaar, E., Ziethen, B. and Gollnick, H. Can a serotonin type 3 (5-HT3) receptor antagonist reduce experimentally-induced itch? Inflam Res 1997, 46: 412-6.
24. Abdouh, M., Albert, P.R., Drobetsky, E., Filep, J.G. and Kouassi E. 5-HT1A-mediated promotion of mitogen-activated T and B cell survival and proliferation is associated with increased translocation of NF-κB to the nucleus. Brain Behav Immun 2004, 18(1): 24-34.
25. Withaker-Azmitia, P.M., Murphy, R.B. and Azmitia, E.C. Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res 1990, 528(1): 155-8.
26. Adayev, T., Ray, I. and Banerjee, P. The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase C-alpha. Biochim Biophys Acta 2003, 1640(1): 85-96.
27. Turner, J.H., Garnovskaya, M.N. and Raymond, J.R. Serotonin 5-HT1A receptor stimulates c-jun N-terminal kinase and induces apoptosis in Chinese hamster ovary fibroblasts. Biochim Biophys Acta 2007, 1773(3): 391-9.
28. Azmitia, E.C., Murphy, R.B. and Whitaker-Azmitia, P.M. MDMA (ecstasy) effects on cultured serotonergic neurons: Evidence for Ca2(+)- dependent toxicity linked to release. Brain Res 1990, 510(1): 97-103.
29. Fricker, A.D., Rios, C., Devi, L.A. and Gomes, I. Serotonin receptor activation leads to neurite outgrowth and neuronal survival. Mol Brain Res 2005, 138(2): 228-35.
30. Carlton, S.M. and Coggeshall, R.E. Immunohistochemical localization of 5-HT2A receptors in peripheral sensory axons in rat glabrous skin. Brain Res 1997, 763(2): 271-5.
31. Kusnir-Sukhov, N.M., Gilfillan, A.M., Coleman, J.W., Brown, J.M., Bruening, S., Toth, M. and Metcalfe, D.D. 5-hydroxytryptamine induces mast cell adhesion and migration. J Immunol 2006, 177(9): 6422-32.
32. El-Nour, H., Lundeberg, L., Abdel-Magid, N., Lonne-Rahm, S.-B., Azmitia, E.C. and Nordlind K. Serotonergic mechanisms in human allergic contact dermatitis. Acta Derm Venereol (Stockh.) 2007, 87(5): 390-6.
33. McAloon, M.H., Chandrasekar, A., Lin, Y.J., Hwang, G.C. and Sharpe, R.J. Buspirone inhibits contact hypersensitivity in the mouse. Int Arch Allergy Appl Immunol 1995, 107(1-3): 437-8.
34. Hashizume, H. and Takigawa, M. Anxiety in allergy and atopic dermatitis. Curr Opin Allergy Clin Immunol 2006, 6(5): 335-9.
35. Sharpe, R.J., Chandrasekar, A., Arndt, K.A., Wang, Z.S. and Galli, S.J. Inhibition of cutaneous hypersensivity in the mouse with systemic or topical spiperone: Topical application of spiperone produces local immunosuppresion without inducing systemic neuroleptic effects. J Invest Dermatol 1992, 99(5): 594-600.
36. Ameisen, J.C., Meade, R. and Askenase P.W. A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells. J Immunol 1989, 142(9): 3171-9.
37. Bondesson, L., Nordlind, K., Mutt, V. and Lidén, S. Inhibitory effect of vasoactive intestinal polypeptide and ketanserin on established allergic contact dermatitis in man. Acta Derm Venereol (Stockh.) 1996, 76(2): 102-6.
38. Lundeberg, L., Mutt, V. and Nordlind, K. Inhibitory effect of vasoactive intestinal peptide on the challenge phase of allergic contact dermatitis in humans. Acta Derm Venereol (Stockh.) 1999, 79(3): 178-82.
39. Greaves, M.W. Itch in systemic disease: Therapeutic options. Derm Ther 2005, 18: 323-7.
40. Krasowska, D., Szymanek, M., Schwartz, R.A. and Myslinski, W. Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors. J Am Acad Dermatol 2007, 56(5): 848-53.
41. Osborne, S.F., Stafford, L. and Orr, K.G.D. Paroxetine-associated psoriasis. Am J Psyciat 2002, 159(2): 2113.
42. Hemlock, C., Rosenthal, J.S. and Winston, A. Fluoxetine-induced psoriasis. Ann Pharmacother 1992, 26(2): 211-2.